- 3.9Impact Factor
- 6.8CiteScore
- 18 daysTime to First Decision
Special Issues
Biomedicines publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Pediatric Tumors: Diagnosis, Pathogenesis, Treatment, and Outcome
Deadline: 30 November 2026
Musculoskeletal Diseases: From Molecular Basis to Therapy—3rd Edition
Deadline: 31 October 2026
Phenotypes and Endotypes in Interstitial Lung Diseases—Second Edition
Deadline: 31 October 2026
From Gut to Vascular Health: The Role of Probiiotics, Polyphenols, and Diet in Neuroinflammation and Cardiovascular Dysfunction
Deadline: 31 October 2026
Feature Reviews in Biomaterials for Oral Diseases
Deadline: 30 September 2026
Emerging Trends in Cardioimmunology: Pathomechanisms and Therapeutic Strategies
Deadline: 30 September 2026
Computed Tomography Cardiac Imaging: Challenges, Current Status, and Advances
Deadline: 30 September 2026
The Peripheral Nervous System: Morphology and Function
Deadline: 30 September 2026
Immunometabolism in Disease Development
Deadline: 30 September 2026
Multiple Sclerosis: Diagnosis and Treatment—3rd Edition
Deadline: 31 August 2026
Periodontal Disease and Periodontal Tissue Regeneration—Second Edition
Deadline: 31 August 2026
Innovative Anticancer Agents: Design, Synthesis and Pharmacological Evaluation
Deadline: 31 August 2026
of 150

